Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | AGS-003 |
Trade Name | |
Synonyms | Rocapuldencel-T |
Drug Descriptions |
AGS-003 (Rocapuldencel-T) is an immunotherapy that comprises autologous dendritic cells transfected with patient tumor-derived RNA and CD40LG (CD40L) RNA, which may result in induction of an anti-tumor immune response (PMID: 25901286, PMID: 32034074). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C77907 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
AGS-003 | AGS-003 | 0 | 1 |
AGS-003 + Sunitinib | AGS-003 Sunitinib | 0 | 0 |